Versant Ventures logo

Versant Ventures

North America, California, United States, Menlo Park

Description

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

Investor Profile

Versant Ventures has made 356 investments, with 8 in the past 12 months and 24% as lead.

Stage Focus

  • Series B (28%)
  • Series A (26%)
  • Series C (17%)
  • Series Unknown (11%)
  • Series D (9%)
  • Series E (3%)
  • Post Ipo Equity (2%)
  • Private Equity (1%)
  • Debt Financing (1%)
  • Series F (1%)

Country Focus

  • United States (88%)
  • Switzerland (6%)
  • Canada (2%)
  • France (1%)
  • Germany (1%)
  • United Kingdom (1%)
  • Sweden (1%)
  • The Netherlands (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
  • Genetics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Versant Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 29
Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 30
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 23
Domain Associates
North America, California, United States, San Diego
Co-Investments: 36
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 20
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 31
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 33
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 21
Venrock
North America, California, United States, Palo Alto
Co-Investments: 20
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 20

Which angels does Versant Ventures often collaborate with?

HW
Europe, Switzerland
Shared Deals: 1
Shared Deals: 1
AZ
North America, California, United States, Mountain View
Shared Deals: 1
Dan Burgess
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Versant Ventures?

Helicore Biopharma

San Mateo, California, United States

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series AJan 28, 2025
Amount Raised: $65,000,000
Light Horse Therapeutics

San Diego, California, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology
Series AJan 9, 2025
Amount Raised: $62,000,000
Antag Therapeutics

Copenhagen, Hovedstaden, Denmark

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series ADec 4, 2024
Amount Raised: $84,098,100
Pep2Tango Therapeutics

Potomac, Maryland, United States

Pep2Tango Therapeutics is a biotechnology company that offers superior unimolecular multi-receptor drugs for obesity and related disorders.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series UnknownNov 21, 2024
Amount Raised: $1,000
858 Therapeutics

San Diego, California, United States

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

BiotechnologyHealth CarePharmaceutical
Series BSep 26, 2024
Amount Raised: $50,000,000
Borealis Biosciences

Vancouver, British Columbia, Canada

Borealis Biosciences is a company in the field of next-generation RNA medicines.

BiotechnologyLife ScienceMedical
Series AAug 22, 2024
Amount Raised: $150,000,000
Bright Peak Therapeutics

Basel, Basel-Stadt, Switzerland

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series CJun 11, 2024
Amount Raised: $90,000,000
SixPeaks Bio

Basel, Basel-Stadt, Switzerland

SixPeaks is developing a pipeline of medicines for healthy weight loss.

BiotechnologyManufacturingPharmaceutical
Series AMay 22, 2024
Amount Raised: $30,000,000
LENZ Therapeutics

Del Mar, California, United States

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Health CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityMar 21, 2024
Amount Raised: $53,500,000
Firefly Bio

San Francisco, California, United States

Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.

BiotechnologyMedical
Series AFeb 15, 2024
Amount Raised: $94,000,000